Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

House Speaker Nancy Pelosi watches President Trump deliver the State of the Union address in the U.S. Capitol in February. Photo: Doug Mills-Pool/Getty Images

House Speaker Nancy Pelosi bluntly cited President Trump's age and speculated on his weight during an appearance on CNN Monday night as reasons why the president should not be taking hydroxychloroquine.

Driving the news: Trump said earlier Monday that he's been taking the antimalarial drug for "about a week and a half" as a preventative measure against the novel coronavirus.

The big picture: The FDA said in a warning last month that the drug should only be taken in hospitals because of the risk of heart complications. Its effectiveness against the virus is unproven.

The other side: Trump's physician Sean Conley said in a statement Monday evening it was decided hydroxychloroquine could be beneficial to Trump after a White House staffer tested positive for COVID-19.

  • "After numerous discussions he and I had regarding the evidence for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks," Conley said.

Editor's note: This story has been updated to correct the spelling of Sean Conley's last name.

Go deeper

Updated Oct 7, 2020 - Health

World coronavirus updates

Expand chart
Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

New Zealand now has active no coronavirus cases in the community after the final six people linked to the Auckland cluster recovered, the country's Health Ministry confirmed in an email Wednesday.

The big picture: The country's second outbreak won't officially be declared closed until there have been "no new cases for two incubation periods," the ministry said. Auckland will join the rest of NZ in enjoying no domestic restrictions from late Wednesday, Prime Minister Jacinda Ardern said, declaring that NZ had "beat the virus again."

Aug 26, 2020 - Health

Fauci says he was having surgery when CDC testing changes were approved

Anthony Fauci was in the operating room under general anesthesia last Thursday when the White House coronavirus task force approved the narrowing of CDC testing recommendations to exclude asymptomatic individuals, according to CNN's Sanjay Gupta.

Why it matters: Fauci, who had vocal cord surgery last week, told Gupta that he is "concerned about the interpretation of these recommendations and worried it will give people the incorrect assumption that asymptomatic spread is not of great concern. In fact, it is."

FDA authorizes Abbott's $5 rapid COVID-19 test

Results from the BinaxNOW COVID-19 Ag Card test will be available in roughly 15 minutes. Photo: Courtesy of Abbott Laboratories.

Abbott Laboratories said Wednesday it received emergency use authorization (EAU) from the Food and Drug Administration for its COVID-19 test that works without lab equipment.

The big picture: Abbott said it will ramp up production of its "highly portable," $5 tests to 50 million by the beginning of October.